Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Millennium/Lilly's gene-based assay for atherosclerosis

Dec. 12, 1996

NOS inhibitors described by Searle

Dec. 12, 1996

Therapeutically active NPY analog reported by academic source

Dec. 9, 1996

Oncogene Science issued patent on gene transcription

Dec. 6, 1996

Anti-E-selectin antisense compound from Isis inhibits mRNA splicing

Dec. 6, 1996

Cytel announces plans for Cylexin at investors conference

Dec. 5, 1996

New endothelin receptor modulators reported by Texas Biotechnology

Dec. 4, 1996

Once-daily antihypertensive combination cleared for marketing in Canada

Dec. 3, 1996

New hope for heart failure patients

Dec. 3, 1996

Therapeutically active NPY analogues reported by Salk Institute

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.